Pharmaco-economic study of the antibiotic treatment of chronic bronchitis crises in primary care;Estudio farmacoeconomico del tratamiento antibiotico de las agudizaciones de la bronquitis cronica en atencion primaria

Atencion Primaria

Volumn 25, Issue 3, 2000, Pages 153-159

  Dafne, G ^a  

^a Pharma Consult Services SA   (Spain)

Author keywords

Antibiotics; Chronic bronchitis; COPD; Cost effectiveness; Crises

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFACLOR; CEFIXIME; CEFONICID; CEFUROXIME AXETIL; CIPROFLOXACIN; CLARITHROMYCIN; ERYTHROMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DRUG COST; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIMARY MEDICAL CARE; ACUTE DISEASE; ANALYSIS OF VARIANCE; BRONCHITIS; CHRONIC DISEASE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; ECONOMICS; MULTICENTER STUDY; PHARMACOECONOMICS; PRIMARY HEALTH CARE; PROSPECTIVE STUDY; SPAIN; STATISTICS;

ACUTE DISEASE; AGED; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; BRONCHITIS; CHRONIC DISEASE; COST-BENEFIT ANALYSIS; ECONOMICS, PHARMACEUTICAL; FEMALE; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MALE; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; SPAIN;

EID: 0034724070     PISSN: 02126567     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0212-6567(00)78479-4     Document Type: Article

References (24)

1. B. Brotons J.A. Pérez F. Sánchez-Toril S. Soriano J. Hernández J.L. Belenguer Prevalencia de la enfermedad pulmonar obstructiva crónica y del asma. Estudio transversal Arch Bronconeumol 30 1994 149 152
2. M. Miravitlles V. Sobradillo C. Villasante R. Gabriel J.F. Masa C.A. Jiménez Estudio epidemiológico de la EPOC en España (IBERPOC): reclutamiento y trabajo de campo Arch Bronconeumol 35 1999 152 158
3. V. Sobradillo M. Miravitlles C.A. Jiménez R. Gabriel J.L. Viejo J.F. Masa Estudio IBERPOC en España: prevalencia de síntomas respiratorios habituales y de limitación crónica al flujo aéreo Arch Bronconeumol 35 1999 159 166
4. A. Jaén A. Ferrer I. Ormaza M. Rué C.h Domingo A. Marín Prevalencia de bronquitis crónica, asma y obstrucción al flujo aéreo en una zona urbano-industrial de Cataluña Arch Bronconeumol 35 1999 122 128
5. L. Marco J.C. Martín M. Corres R. Luque G. Zubillaga Enfermedad pulmonar obstructiva crónica en la población general. Estudio epidemiológico realizado en Guipúzcoa Arch Bronconeumol 34 1998 23 27
6. P.G. Davey M.M. Malek S.E. Parker Pharmacoeconomics of antibacterial treatment PharmacoEconomics 1 1992 409 437
7. M. Miravitlles C. Mayordomo T. Artés L. Sánchez-Agudo F. Nicolau Segú JL and the EOLO Group. Treatment of chronic obstructive pulmonary disease and its exacerbations in General Practice Respir Med 93 1999 173 179
8. M. Miravitlles C. Murio T. Guerrero Segú JL. Tratamiento de la bronquitis crónica y la EPOC en atención primaria Arch Bronconeumol 35 1999 173 178
9. T. Montemayor Y. Alfajeme C. Escudero J. Morera L. Sánchez Agudo Normativa sobre diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica Arch Bronconeumol 32 1996 285 301
10. N.R. Anthonisen J. Manfreda C.P.W. Warren E.S. Hershfield G.K.M. Harding N.A. Nelson Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease Ann Intern Med 106 1987 196 204
11. G.K. Kong M.J. Belman S. Weingarten Reducing length of stay for patients hospitalized with exacerbation of COPD by using a practice guideline Chest 111 1997 89 94
12. J.T. MacFarlane A. Colville A. Guion R.M. MacFarlane D.H. Rose Estudio prospectivo sobre etiología y evolución de las infecciones respiratorias bajas extrahospitalarias en el adulto. Lancet (ed esp.) 23 1993 12 15
13. W.G. Scott M.W. Tilyard S.M. Dovey B. Cooper H.M. Scott Roxitromycin vs cefaclor in lower respiratory tract infection: a general practice pharmacoeconomic study PharmacoEconomics 4 1993 122 130
14. J.A. Sacristán J. Soto J. Reviriego I. Galende Farmacoeconomía: el cálculo de la eficiencia Med Clin (Barc) 103 1994 143 149
15. H.K.F. Van Saene F.T.C. Willems R.J. Davies The abnormal carrier state and superinfection following antibiotic treatment of respiratory tract infection in general prectice: a clinical, controlled trial Eur Respir Rev 2 1991 193 198
16. K. Groeneveld L. Van ALphen P.P. Eijk G. Visschers H.M. Jansen H.C. Zanen Endogenous and exogenous reinfections by Haemophilus influenzae in patients with chronic obstructive pulmonary disease: the effect of antibiotic treatment on persistence J Infect Dis 161 1990 512 517
17. A. Hillman Cost-effectiveness opportunities for new antibiotics PharmacoEconomics 5 Supl 2 1994 40 43
18. P. Davey D. Rutherford B. Graham B. Lynch B. Malek Repeat consultations after antibiotic prescribing for respiratory infection: a study in one general practice Br J Gen Pract 44 1994 509 513
19. M. Miravitlles C. Mayordomo M.T. Artés L. Sánchez-Agudo T. Guerrero Segú JL y Grupo EOLO. Factores que influyen sobre el tiempo libre de agudizaciones en la EPOC. Resultados del seguimiento del estudio EOLO Arch Bronconeumol 33 Supl 1 1997 10
20. P. Ball J.M. Harris D. Lowson G. Tillotson R. Wilson Acute infective exacerbations of chronic bronchitis Q J Med 88 1995 61 68
21. T.A.R. Seemungal G.C. Donaldson E.A. Paul J.C. Bestall D.J. Jeffries J.A. Wedzicha Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 157 1998 1418 1422
22. B. Burrows R.H. Earle Course and prognosis of chronic obstructive lung disease: a prospective study of 200 patients N Engl J Med 280 1969 397 404
23. R. Grossman J. Mukherjee D. Vaughan C. Eastwood R. Cook J. LaForge A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis Chest 113 1998 131 141
24. M. Miravitlles C. Espinosa E. Fernández-Laso J.A. Martos J.A. Maldonado Gallego M and Study Group of Bacterial Infection in COPD. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD Chest 116 1999 40 46